Bioequivalence Evaluation of Three Pediatric Oral Formulations of Bilastine in Healthy Subjects: Results from a Randomized, Open Label, Crossover Study

被引:0
|
作者
Belén Sádaba
Jose Ramón Azanza
Aintzane García-Bea
Luis Labeaga
Cristina Campo
Román Valiente
机构
[1] Clínica Universidad de Navarra,Clinical Pharmacology Service
[2] IdiSNA,Medical Department
[3] Navarra Institute for health Research,Clinical Research Department
[4] Faes Farma S. A.,undefined
[5] Faes Farma S. A.,undefined
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:265 / 272
页数:7
相关论文
共 50 条
  • [1] Bioequivalence Evaluation of Three Pediatric Oral Formulations of Bilastine in Healthy Subjects: Results from a Randomized, Open Label, Crossover Study
    Sadaba, Belen
    Azanza, Jose Ramon
    Garcia-Bea, Aintzane
    Labeaga, Luis
    Campo, Cristina
    Valiente, Roman
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2020, 45 (02) : 265 - 272
  • [2] Bioequivalence Evaluation of Two Oral Formulations of Acetaminophen in Healthy Subjects: Results From a Randomized, Single-Blind, Crossover Study
    Garcia Aguirre, Luis
    Bohorquez Nassar, Carlos
    Ruiz Olmedo, Isabel
    Dennie, Lara
    Medina Nolasco, Araceli G.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2019, 8 (01): : 9 - 15
  • [3] Bioequivalence evaluation of perampanel oral suspension and tablet formulations in healthy subjects: a Phase I, open-label, crossover study
    Laurenza, Antonio
    Hall, Nancy
    Majid, Oneeb
    Rege, Bhaskar
    NEUROLOGY, 2017, 88
  • [4] Bioequivalence Study of Two Oral Methocarbamol Formulations in Healthy Subjects Under Fasting Conditions: A Randomized, Open-Label, Crossover Clinical Trial
    Ascaso-del-Rio, Ana
    Camargo-Mamani, Paola
    Gilaberte, Inmaculada
    Diez-Hochleitner, Monica
    Laredo-Velasco, Leonor
    Iglesias-Hernangomez, Teresa
    Salas-Butron, Maria Rosario
    Caballero, Laura Galan
    Diaz-Rengifo, Ivan Alejandro
    Perez-Ingidua, Carla
    Vargas-Castrillon, Emilio
    Portoles-Perez, Antonio
    PHARMACEUTICALS, 2025, 18 (03)
  • [5] A randomized, open-label, crossover study evaluating bioequivalence of two N-acetylcysteine 2% oral solution formulations in healthy subjects
    Donath, Frank
    Armogida, Marianna
    Shneyer, Lucy
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2018, 56 (09) : 417 - 425
  • [6] Bioequivalence study of oral pimavanserin capsule in healthy adult volunteers: Results from a randomized, crossover, open-label study
    Kumar, Sudershan
    Tiwari, Neeta
    Devkare, Prashant
    Bedi, Simrata
    Khuroo, Arshad
    Singh, Romi
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [7] A PHASE 1 OPEN-LABEL CROSSOVER STUDY TO EVALUATE BIOEQUIVALENCE OF ORAL SUSPENSION AND TABLET FORMULATIONS OF PERAMPANEL IN HEALTHY SUBJECTS
    Laurenza, A.
    Hall, N.
    Majid, O.
    Rege, B.
    EPILEPSIA, 2016, 57 : 170 - 171
  • [8] Comparative crossover, randomized, open-label bioequivalence study on the bioequivalence of two formulations of thioctic acid in healthy volunteers
    Mignini, Fiorenzo
    Streccioni, Valentino
    Tomassoni, Daniele
    Traini, Enea
    Amenta, Francesco
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2007, 29 (08) : 575 - 586
  • [9] Pharmacokinetics of oral pridinol: Results of a randomized, crossover bioequivalence trial in healthy subjects
    Richter, Maren
    Donath, Frank
    Wedemeyer, Ralph-Steven
    Warnke, Andre
    Horstmann, Andreas
    Peschel, Claudia
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2021, 59 (06) : 471 - 477
  • [10] Pharmacokinetics and bioequivalence of sunitinib and Sutent® in Chinese healthy subjects: an open-label, randomized, crossover study
    Wang, Yanli
    Deng, Qiaohuan
    Gao, Zhenyue
    Liu, Guangwen
    Su, Zhengjie
    Zhao, Yicheng
    Zhang, Lixiu
    Yang, Haimiao
    FRONTIERS IN PHARMACOLOGY, 2023, 14